Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

PLXDC1 anticorps (C-Term)

PLXDC1 Reactivité: Humain WB Hôte: Lapin Polyclonal RB30617 unconjugated
N° du produit ABIN1881662
  • Antigène Voir toutes PLXDC1 Anticorps
    PLXDC1 (Plexin Domain Containing 1 (PLXDC1))
    Épitope
    • 12
    • 7
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 466-494, C-Term
    Reactivité
    • 35
    • 6
    • 6
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 30
    • 5
    Lapin
    Clonalité
    • 31
    • 4
    Polyclonal
    Conjugué
    • 18
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp PLXDC1 est non-conjugé
    Application
    • 26
    • 18
    • 7
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Purification
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogène
    This PLXDC1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 466-494 amino acids from the C-terminal region of human PLXDC1.
    Clone
    RB30617
    Isotype
    Ig Fraction
    Top Product
    Discover our top product PLXDC1 Anticorps primaire
  • Indications d'application
    WB: 1:1000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Date de péremption
    6 months
  • Halder, Ossendorf, Maran, Yaszemski, Bolander, Fuchs, Sarkar: "Preferential expression of the secreted and membrane forms of tumor endothelial marker 7 transcripts in osteosarcoma." dans: Anticancer research, Vol. 29, Issue 11, pp. 4317-22, (2009) (PubMed).

    Yamaji, Yoshida, Ishikawa, Sengoku, Sato, Yoshida, Kuwahara, Ohuchida, Oki, Enaida, Fujisawa, Kono, Ishibashi: "TEM7 (PLXDC1) in neovascular endothelial cells of fibrovascular membranes from patients with proliferative diabetic retinopathy." dans: Investigative ophthalmology & visual science, Vol. 49, Issue 7, pp. 3151-7, (2008) (PubMed).

    Fuchs, Mahlum, Halder, Maran, Yaszemski, Bode, Bolander, Sarkar: "High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma." dans: Gene, Vol. 399, Issue 2, pp. 137-43, (2007) (PubMed).

    Nanda, Buckhaults, Seaman, Agrawal, Boutin, Shankara, Nacht, Teicher, Stampfl, Singh, Vogelstein, Kinzler, St Croix: "Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7R." dans: Cancer research, Vol. 64, Issue 23, pp. 8507-11, (2004) (PubMed).

  • Antigène
    PLXDC1 (Plexin Domain Containing 1 (PLXDC1))
    Autre désignation
    PLXDC1 (PLXDC1 Produits)
    Synonymes
    anticorps PLXDC1, anticorps TEM3, anticorps TEM7, anticorps 2410003I07Rik, anticorps AI848450, anticorps Tem7, anticorps Arl12, anticorps plexin domain containing 1, anticorps PLXDC1, anticorps Plxdc1
    Sujet
    Plays a critical role in endothelial cell capillary morphogenesis.
    Poids moléculaire
    55760
    NCBI Accession
    NP_065138
    UniProt
    Q8IUK5
Vous êtes ici:
Support technique